Hero

Team

Volodymyr (Vlad) Nikolenko, PhD, MBA

Volodymyr (Vlad) Nikolenko, PhD, MBA

Vice President, Research & Investments

Dr. Nikolenko joined Royalty Pharma in 2017. Previously, Dr. Nikolenko was an equity research associate on the Evercore ISI biotech and pharma team. Mr. Nikolenko also previously was a senior financial analyst at Merck and a senior portfolio analyst at Columbia Technology Ventures. Dr. Nikolenko has a BS/MS from Moscow Institute of Physics and Technology, an MBA from Columbia University, and a PhD in neuroscience from Columbia University.